These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8455088)

  • 1. Methods for improving quantitation of putamen uptake constant of FDOPA in PET studies.
    Yu DC; Huang SC; Grafton ST; Melega WP; Barrio JR; Mazziotta JC; Phelps ME
    J Nucl Med; 1993 Apr; 34(4):679-88. PubMed ID: 8455088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined FDOPA and 3OMFD PET studies in Parkinson's disease.
    Dhawan V; Ishikawa T; Patlak C; Chaly T; Robeson W; Belakhlef A; Margouleff C; Mandel F; Eidelberg D
    J Nucl Med; 1996 Feb; 37(2):209-16. PubMed ID: 8667046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease.
    Ishikawa T; Dhawan V; Chaly T; Margouleff C; Robeson W; Dahl JR; Mandel F; Spetsieris P; Eidelberg D
    J Nucl Med; 1996 Feb; 37(2):216-22. PubMed ID: 8667047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
    Kuwabara H; Cumming P; Yasuhara Y; Léger GC; Guttman M; Diksic M; Evans AC; Gjedde A
    J Nucl Med; 1995 Jul; 36(7):1226-31. PubMed ID: 7790948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal 18F-dopa uptake: absence of an aging effect.
    Eidelberg D; Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Margouleff D; Moeller JR; Patlak CS; Fahn S
    J Cereb Blood Flow Metab; 1993 Sep; 13(5):881-8. PubMed ID: 8360294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
    Ishikawa T; Dhawan V; Chaly T; Robeson W; Belakhlef A; Mandel F; Dahl R; Margouleff C; Eidelberg D
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):854-63. PubMed ID: 8784230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels.
    Criswell SR; Perlmutter JS; Crippin JS; Videen TO; Moerlein SM; Flores HP; Birke AM; Racette BA
    Arch Neurol; 2012 Mar; 69(3):394-7. PubMed ID: 22410448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations.
    Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Zanzi I; Mandel F; Spetsieris P; Eidelberg D
    J Nucl Med; 1994 Jun; 35(6):955-63. PubMed ID: 8195882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
    Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
    Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assessment of the non-equilibrium effect in the 'Patlak analysis' of Fdopa PET studies.
    Yu DC; Huang SC; Barrio JR; Phelps ME
    Phys Med Biol; 1995 Jul; 40(7):1243-54. PubMed ID: 7568380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated striatal uptake analysis of ¹⁸F-FDOPA PET images applied to Parkinson's disease patients.
    Chang IC; Lue KH; Hsieh HJ; Liu SH; Kao CH
    Ann Nucl Med; 2011 Dec; 25(10):796-803. PubMed ID: 21887536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
    Cumming P; Léger GC; Kuwabara H; Gjedde A
    J Cereb Blood Flow Metab; 1993 Jul; 13(4):668-75. PubMed ID: 8314919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrastriatal mean regional uptake of fluorine-18-FDOPA in the normal aged brain--an approach using MRI-aided spatial normalization.
    Nagano AS; Ito K; Kato T; Arahata Y; Kachi T; Hatano K; Kawasumi Y; Nakamura A; Yamada T; Abe Y; Ishigaki T
    Neuroimage; 2000 Jun; 11(6 Pt 1):760-6. PubMed ID: 10860800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.
    Vernaleken I; Kumakura Y; Cumming P; Buchholz HG; Siessmeier T; Stoeter P; Müller MJ; Bartenstein P; Gründer G
    Neuroimage; 2006 May; 30(4):1332-9. PubMed ID: 16439159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-[18F]fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography.
    Nagasawa H; Saito H; Kogure K; Hatazawa J; Itoh M; Fujiwara T; Watanuki S; Seo S; Iwata R; Ido T
    J Neurol Sci; 1993 Apr; 115(2):136-43. PubMed ID: 8482975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.
    Ma Y; Feigin A; Dhawan V; Fukuda M; Shi Q; Greene P; Breeze R; Fahn S; Freed C; Eidelberg D
    Ann Neurol; 2002 Nov; 52(5):628-34. PubMed ID: 12402261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment.
    Lizarraga KJ; Allen-Auerbach M; Czernin J; DeSalles AA; Yong WH; Phelps ME; Chen W
    J Nucl Med; 2014 Jan; 55(1):30-6. PubMed ID: 24167081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual time point method for the quantification of irreversible tracer kinetics: A reference tissue approach applied to [
    Lopes Alves I; Meles SK; Willemsen AT; Dierckx RA; Marques da Silva AM; Leenders KL; Koole M
    J Cereb Blood Flow Metab; 2017 Sep; 37(9):3124-3134. PubMed ID: 28156211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
    Huang SC; Yu DC; Barrio JR; Grafton S; Melega WP; Hoffman JM; Satyamurthy N; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):898-913. PubMed ID: 1939385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
    Melega WP; Grafton ST; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):890-7. PubMed ID: 1939384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.